Symposium 9 (open)
Gamma-Aminobutyric Acid and Glutamate Dysregulation in Child and Adolescent Psychiatric Disorders

Wednesday, October 23, 2013: 1:00 PM-4:00 PM
Chair:
Paul E. Croarkin, DO
Discussant:
Steven R. Pliszka, MD
 
9.1
Introduction to the Gamma-Aminobutyric Acid and Glutamate Neurotransmitter Systems
Charles Lewis, MD Mayo Clinic, Rochester, MN
 
9.2
Glutamate and Gamma-Aminobutyric Acid in Pediatric Anxiety Disorders: Drawing a Map to Neurobiologically-Informed Treatment
Jeffrey Robert Strawn, MD University of Cincinnati, Cincinnati, OH
 
9.3
The Role of Glutamate and Gamma-Aminobutyric Acid in Autism Spectrum Disorders: Pilot Results from a Proton Magnetic Resonance Spectroscopy Study
David Cochran, MD, PhD University of Massachusetts Medical School, Marlborough, MA
 
9.4
Role of Nucleus Accumbens Dopamine in the Antidepressant Response: A Neuromodulator at the Interface of Glutamate and Gamma-Aminobutyric Acid
Susannah Tye, PhD Mayo Clinic, Rochester, MN
 
9.5
Gamma-Aminobutyric Acid Dysregulation in Adolescent Depression
Vilma Gabbay, M.D., M.S. Mount Sinai School of Medicine, New York, NY
Benjamin A. Ely, BS Mount Sinai School of Medicine, New York, NY
 
9.6
Glutamatergic Cortical Facilitation in Children and Adolescents with Major Depressive Disorder
Paul E. Croarkin, DO Mayo Clinic, Rochester, MN

See more of: Symposium
Copyright ©2013 - American Academy of Child Adolescent Psychiatry. All Rights Reserved.